Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I504
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.400 |
CLV_NRD_NRD_1 | 118 | 120 | PF00675 | 0.421 |
CLV_NRD_NRD_1 | 123 | 125 | PF00675 | 0.501 |
CLV_NRD_NRD_1 | 128 | 130 | PF00675 | 0.444 |
CLV_NRD_NRD_1 | 134 | 136 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 151 | 153 | PF00675 | 0.465 |
CLV_NRD_NRD_1 | 158 | 160 | PF00675 | 0.501 |
CLV_NRD_NRD_1 | 170 | 172 | PF00675 | 0.475 |
CLV_NRD_NRD_1 | 176 | 178 | PF00675 | 0.527 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.416 |
CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.494 |
CLV_NRD_NRD_1 | 43 | 45 | PF00675 | 0.519 |
CLV_NRD_NRD_1 | 50 | 52 | PF00675 | 0.417 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.513 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.485 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.522 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.515 |
CLV_NRD_NRD_1 | 98 | 100 | PF00675 | 0.415 |
CLV_PCSK_FUR_1 | 116 | 120 | PF00082 | 0.414 |
CLV_PCSK_FUR_1 | 17 | 21 | PF00082 | 0.513 |
CLV_PCSK_FUR_1 | 29 | 33 | PF00082 | 0.471 |
CLV_PCSK_FUR_1 | 79 | 83 | PF00082 | 0.575 |
CLV_PCSK_FUR_1 | 96 | 100 | PF00082 | 0.459 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.400 |
CLV_PCSK_KEX2_1 | 118 | 120 | PF00082 | 0.421 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.501 |
CLV_PCSK_KEX2_1 | 128 | 130 | PF00082 | 0.444 |
CLV_PCSK_KEX2_1 | 134 | 136 | PF00082 | 0.455 |
CLV_PCSK_KEX2_1 | 151 | 153 | PF00082 | 0.465 |
CLV_PCSK_KEX2_1 | 158 | 160 | PF00082 | 0.498 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 176 | 178 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 19 | 21 | PF00082 | 0.418 |
CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.510 |
CLV_PCSK_KEX2_1 | 50 | 52 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.513 |
CLV_PCSK_KEX2_1 | 8 | 10 | PF00082 | 0.530 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.485 |
CLV_PCSK_KEX2_1 | 90 | 92 | PF00082 | 0.515 |
CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.415 |
CLV_PCSK_PC7_1 | 119 | 125 | PF00082 | 0.585 |
CLV_PCSK_PC7_1 | 147 | 153 | PF00082 | 0.561 |
CLV_PCSK_PC7_1 | 86 | 92 | PF00082 | 0.551 |
CLV_PCSK_PC7_1 | 94 | 100 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.593 |
DEG_APCC_DBOX_1 | 7 | 15 | PF00400 | 0.517 |
DOC_ANK_TNKS_1 | 151 | 158 | PF00023 | 0.537 |
DOC_USP7_MATH_1 | 199 | 203 | PF00917 | 0.626 |
DOC_USP7_MATH_1 | 62 | 66 | PF00917 | 0.516 |
LIG_14-3-3_CanoR_1 | 44 | 54 | PF00244 | 0.596 |
LIG_14-3-3_CanoR_1 | 81 | 89 | PF00244 | 0.552 |
LIG_BRCT_BRCA1_1 | 79 | 83 | PF00533 | 0.536 |
LIG_FHA_2 | 206 | 212 | PF00498 | 0.589 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.594 |
LIG_Integrin_RGD_1 | 119 | 121 | PF01839 | 0.569 |
LIG_LIR_Apic_2 | 36 | 42 | PF02991 | 0.616 |
LIG_LIR_Nem_3 | 110 | 115 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 95 | 100 | PF02991 | 0.518 |
LIG_RPA_C_Fungi | 147 | 159 | PF08784 | 0.545 |
LIG_SH2_CRK | 39 | 43 | PF00017 | 0.617 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.593 |
LIG_TRAF2_1 | 208 | 211 | PF00917 | 0.586 |
MOD_CK2_1 | 205 | 211 | PF00069 | 0.604 |
MOD_CK2_1 | 49 | 55 | PF00069 | 0.591 |
MOD_Cter_Amidation | 121 | 124 | PF01082 | 0.584 |
MOD_Cter_Amidation | 126 | 129 | PF01082 | 0.545 |
MOD_Cter_Amidation | 156 | 159 | PF01082 | 0.533 |
MOD_Cter_Amidation | 167 | 170 | PF01082 | 0.521 |
MOD_Cter_Amidation | 174 | 177 | PF01082 | 0.505 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.612 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.524 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.589 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.606 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.616 |
MOD_PKA_1 | 20 | 26 | PF00069 | 0.521 |
MOD_PKA_1 | 81 | 87 | PF00069 | 0.595 |
MOD_PKA_2 | 140 | 146 | PF00069 | 0.613 |
MOD_PKA_2 | 163 | 169 | PF00069 | 0.571 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.521 |
MOD_PKA_2 | 49 | 55 | PF00069 | 0.547 |
MOD_PKA_2 | 81 | 87 | PF00069 | 0.595 |
MOD_PKB_1 | 169 | 177 | PF00069 | 0.613 |
MOD_PKB_1 | 79 | 87 | PF00069 | 0.557 |
TRG_ER_diArg_1 | 115 | 118 | PF00400 | 0.419 |
TRG_ER_diArg_1 | 123 | 125 | PF00400 | 0.560 |
TRG_ER_diArg_1 | 128 | 130 | PF00400 | 0.502 |
TRG_ER_diArg_1 | 134 | 137 | PF00400 | 0.435 |
TRG_ER_diArg_1 | 138 | 141 | PF00400 | 0.495 |
TRG_ER_diArg_1 | 158 | 161 | PF00400 | 0.414 |
TRG_ER_diArg_1 | 169 | 171 | PF00400 | 0.500 |
TRG_ER_diArg_1 | 17 | 20 | PF00400 | 0.430 |
TRG_ER_diArg_1 | 31 | 33 | PF00400 | 0.464 |
TRG_ER_diArg_1 | 42 | 44 | PF00400 | 0.517 |
TRG_ER_diArg_1 | 50 | 53 | PF00400 | 0.438 |
TRG_ER_diArg_1 | 68 | 70 | PF00400 | 0.489 |
TRG_ER_diArg_1 | 78 | 81 | PF00400 | 0.518 |
TRG_ER_diArg_1 | 8 | 10 | PF00400 | 0.530 |
TRG_ER_diArg_1 | 89 | 91 | PF00400 | 0.506 |
TRG_ER_diArg_1 | 97 | 99 | PF00400 | 0.409 |
TRG_Pf-PMV_PEXEL_1 | 12 | 16 | PF00026 | 0.507 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7X2W4 | Leishmania donovani | 97% | 97% |
A4HHV4 | Leishmania braziliensis | 61% | 96% |
E9B0D4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q7U6 | Leishmania major | 93% | 100% |